News and Trends 14 Feb 2023
Scancell looking to partner after positive COVID vaccine data
Scancell Holdings plc, which develops novel immunotherapies for the treatment of cancer and infectious disease, has announced preliminary immunogenicity data from its phase 1 COVIDITY clinical trial at the University…